From DCAT Value Chain Insights (VCI)
GlaxoSmithKline (GSK) has appointed Brian McNamara as chief executive officer (CEO) of GSK’s consumer healthcare division effective immediately. He succeeds Emma Walmsley who was recently appointed GSK CEO designate succeeding Andrew Witty as GSK CEO when he retires in March 2017. In his new role, Mr. McNamara will report to Mr. Witty until Ms. Walmsley becomes CEO. Mr. McNamara will join GSK’s corporate executive team effective immediately and will continue as a member of the board of the Consumer Healthcare Joint Venture with Novartis. He will be based in the UK.
Mr. NcNamara is currently head of Europe & Americas at GSK consumer healthcare. He joined GSK from Novartis following completion of GSK’s three-part transaction with Novartis and has been a member of GSK’s consumer healthcare executive team since 2015. Prior to joining GSK, he spent 11 years at Novartis and 16 years at Procter & Gamble. Source: GlaxoSmithKline
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription